Biotechnology Breakthrough: Podophyllotoxin and A-Peltatin Inhibit NF-kB Activation

Recent research from the Kyoto Institute of Technology has shed light on the potential therapeutic applications of podophyllotoxin and its derivative a-peltatin. In a groundbreaking study, researchers discovered that these compounds inhibit the activation of nuclear factor kappa B (NF-kB), a key transcription factor involved in inflammation and immune responses. This finding has significant implications for the development of new treatments for various diseases, including those involving vascular inflammation.

Key Takeaways:

• Podophyllotoxin and a-peltatin were identified as potent inhibitors of NF-kB activation in human umbilical vein endothelial cells (HUVEC).
• The compounds inhibited the expression of adhesion molecules, including ICAM-1, VCAM-1, and E-selectin, which are involved in inflammation and immune responses.
• The researchers found that the compounds also inhibited the nuclear translocation of the NF-kB subunit RelA, a key step in NF-kB activation.
• Microtubule-targeting agents, such as colchicine and paclitaxel, exerted different effects on NF-kB activation in HUVEC.
• Vinblastine, a microtubule-targeting agent, potently inhibited nuclear RelA translocation in Poly(I: C)-stimulated HUVEC.
• The findings of this study demonstrate the potential therapeutic applications of podophyllotoxin and a-peltatin in treating diseases involving vascular inflammation.

Statistics:

• The study involved the screening of 13,266 compounds from the RIKEN Natural Products Depository chemical libraries.
• Podophyllotoxin and a-peltatin were identified as the most potent inhibitors of NF-kB activation among the screened compounds.
• The IC50 values for podophyllotoxin and a-peltatin were 10.39 ± 0.61 μM and 17.54 ± 1.25 μM, respectively.
• The mRNA expression of ICAM-1, VCAM-1, and E-selectin was inhibited by 50.6% ± 5.4%, 62.4% ± 6.8%, and 73.2% ± 7.1%, respectively, in Poly(I: C)-stimulated HUVEC treated with podophyllotoxin and a-peltatin.
• The study was published in Bioscience, Biotechnology, and Biochemistry in 2025.

Sources:

• Podophyllotoxin and a-peltatin inhibit nuclear factor kB activation and gene expression stimulated by a double-stranded RNA analogue in human umbilical vein endothelial cells. Bioscience, Biotechnology, and Biochemistry, 2025.
• Kyoto Institute of Technology Reports Findings in Biotechnology and Biochemistry (Podophyllotoxin and a-peltatin inhibit nuclear factor kB activation and gene expression stimulated by a double-stranded RNA analogue in human umbilical vein ...). Chemicals & Chemistry. August 8, 2025; p 2116.